<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0372772</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3705</journal-id>
<journal-id journal-id-type="nlm-ta">Fertil Steril</journal-id>
<journal-id journal-id-type="iso-abbrev">Fertil. Steril.</journal-id>
<journal-title-group>
<journal-title>Fertility and sterility</journal-title>
</journal-title-group>
<issn pub-type="ppub">0015-0282</issn>
<issn pub-type="epub">1556-5653</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29447663</article-id>
<article-id pub-id-type="pmc">5856154</article-id>
<article-id pub-id-type="doi">10.1016/j.fertnstert.2018.01.005</article-id>
<article-id pub-id-type="manuscript">NIHMS938488</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Prenatal Diagnosis by Chromosomal Microarray Analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Levy</surname>
<given-names>Brynn</given-names>
</name>
<degrees>PhD, MSc</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wapner</surname>
<given-names>Ronald</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Columbia University Medical Center, Department of Pathology &amp; Cell Biology</aff>
<aff id="A2">
<label>2</label>Columbia University Medical Center, Department of Obstetrics &amp; Gynecology</aff>
<pub-date pub-type="nihms-submitted">
<day>16</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>109</volume>
<issue>2</issue>
<fpage>201</fpage>
<lpage>212</lpage>
<!--elocation-id from pubmed: 10.1016/j.fertnstert.2018.01.005-->
<abstract>
<p id="P1">Chromosomal microarray analysis (CMA) is performed either by array comparative genomic hybridization (aCGH) or by using a SNP array. In the prenatal setting, CMA is on par with traditional karyotyping for detection of major chromosomal imbalances such as aneuploidy and unbalanced rearrangements. CMA offers additional diagnostic benefits by revealing sub-microscopic imbalances or copy number changes (CNVs) that are too small to be seen on a standard G-banded chromosome preparation. These submicroscopic imbalances are also referred to as microdeletions and microduplications, particularly when they include specific genomic regions that are associated with clinical sequelae. Not all microdeletions/duplications are associated with adverse clinical phenotypes and in many cases, their presence is benign. In other cases, they are associated with a spectrum of clinical phenotypes that may range from benign to severe, while in some situations, the clinical significance may simply be unknown. These scenarios present a challenge for prenatal diagnosis and genetic counseling prior to prenatal CMA greatly facilitates delivery of complex results. In prenatal diagnostic samples with a normal karyotype, chromosomal microarray will diagnose a clinically significant subchromosomal deletion or duplication in approximately 1% of structurally normal pregnancies and 6% with a structural anomaly. Pre-test counseling is also necessary to distinguish the primary differences between the benefits, limitations and diagnostic scope of CMA versus the powerful but limited screening nature of non-invasive prenatal diagnosis using cell-free fetal DNA.</p>
</abstract>
<kwd-group>
<kwd>chromosomal microarray</kwd>
<kwd>prenatal diagnosis</kwd>
<kwd>amniocentesis</kwd>
<kwd>chorionic villus sampling</kwd>
<kwd>microdeletion</kwd>
<kwd>microduplication</kwd>
<kwd>copy number variation</kwd>
<kwd>CNV</kwd>
<kwd>VOUS</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>